Pulmonary embolism: Difference between revisions
| Line 32: | Line 32: | ||
====Moderate Probability==== | ====Moderate Probability==== | ||
* | *D-dimer | ||
** | **However, it is unclear whether d-dimer alone is sufficient to rule-out PE<ref>ACEP Clinical Policy. http://www.acep.org/Content.aspx?id=80787 </ref> | ||
====High Probability==== | ====High Probability==== | ||
Revision as of 08:20, 22 December 2014
See Pulmonary Embolism in Pregnancy for pregnancy specific information.[1]
Background
Clinical Spectrum of Venous Thromboembolism
Clinical Spectrum of Venous thromboembolism (VTE)
- Deep venous thrombosis (uncomplicated)
- Phlegmasia alba dolens
- Phlegmasia cerulea dolens
- Venous gangrene
- Pulmonary embolism
- Isolated distal deep venous thrombosis
Only 40% of ambulatory ED patients with PE have concomitant DVT[2][3]
Types
Clinical Presentation
Symptoms
- Dyspnea at rest or with exertion (75-80%)
- Chest pain (66%)
- Pleuritic pain, pain that halts respiration, is only seen in 20% of patients
- Cough
- Hemoptysis
- Unilateral calf swelling
- Syncope
- Syncope is caused by PE <5% of the time
Signs
- Tachycardia (HR>100), Tachypnea (RR>20), Hypoxemia (SpO2<95%) are seen ~50% of the time
- Hypotension (SBP<90) only seen 10% of the time, but largest predictor of mortality
- Unilateral calf tenderness or edema, suggestive of a DVT
- Other signs may include accentuated pulmonic component of second heart sound, JVD, or decreased breath sounds
Diagnosis
Wells Criteria
- Symptoms of DVT - 3pts
- No alternative diagnosis better explains the illness - 3pts
- HR > 100 - 1.5 pts
- Immobilization within prior 4wks - 1.5pts
- Prior history of DVT or PE - 1.5pts
- Active malignancy - 1pt
- Hemoptysis - 1pt
Wells Score
- 0-1 point: Low probability (3.4%)
- 2-6 points: Moderate probability (27.8%)
- 7-12 points: High probability (78.4%)
Workup by Probability
Low Probability
Moderate Probability
- D-dimer
- However, it is unclear whether d-dimer alone is sufficient to rule-out PE[4]
High Probability
- Consider anticoagulation before imaging!
- CTPA if GFR >60
- V/Q if GFR <60
Differential Diagnosis
Chest pain
Critical
- Acute coronary syndromes (ACS)
- Aortic dissection
- Cardiac tamponade
- Coronary artery dissection
- Esophageal perforation (Boerhhaave's syndrome)
- Pulmonary embolism
- Tension pneumothorax
Emergent
- Cholecystitis
- Cocaine-associated chest pain
- Mediastinitis
- Myocardial rupture
- Myocarditis
- Pancreatitis
- Pericarditis
- Pneumothorax
Nonemergent
- Aortic stenosis
- Arthritis
- Asthma exacerbation
- Biliary colic
- Costochondritis
- Esophageal spasm
- Gastroesophageal reflux disease
- Herpes zoster / Postherpetic Neuralgia
- Hypertrophic cardiomyopathy
- Hyperventilation
- Mitral valve prolapse
- Panic attack
- Peptic ulcer disease
- Pleuritis
- Pneumomediastinum
- Pneumonia
- Rib fracture
- Stable angina
- Thoracic outlet syndrome
- Valvular heart disease
- Muscle sprain
- Psychologic / Somatic Chest Pain
- Spinal Root Compression
- Tumor
Treatment
Supportive care
- Give IVF to increase preload
Anticoagulation
- Indicated for all patients with confirmed PE or high clinical suspicion (don't wait for imaging)
- Treatment options:
- LMWH SC
- 1st line for most hemodynamically stable pts
- contraindicated in renal failure
- Enoxaparin 1 mg/kg SC q12h
- Dalteparin 200 IU/kg SC q24h, max 18,000 IU
- Unfractionated Heparin
- Consider in pts w/:
- Persistent hypotension
- Increased risk of bleeding
- Recent sx/trauma
- Renal failure (GFR <30)
- Morbid obesity or anasarca (poor sc absorption)
- Thrombolysis is being considered
- 80 units/kg bolus; then 18 units/kg/hr
- Check PTT after 6hr; adjust infusion to maintain PTT at 1.5-2.5x control
- Consider in pts w/:
- LMWH SC
Thrombolysis
- Major controversy exists regarding thrombolytic therapy in submassive PE. Therapy should be individualized to patients.[5][6][7] 'The mortality benefit may be greatest in patients with right ventricular dysfunction. [8]
- Bleeding risk is increased with increasing age especially in the group ≥ 65 yo[9]
Indications
- Patients with massive PE and acceptable risk of bleeding complications
- Pt w/ submassive PE w/ evidence adverse prognosis + low risk of bleeding complications
- Hemodynamic instability
- Worsening respiratory insufficiency
- Severe Right Ventricular dysfunction
- Major myocardial necrosis
Thrombolytic Instructions
- Review contraindications
- Discontinue heparin during infusion
- tPA 100mg over 2hr OR 0.6 mg/kg over 2min
- After infusion complete measure PTT
- Once value is <2x upper limit restart anticoagulation
Absolute contraindications
- Any prior intracranial hemorrhage,
- Known structural intracranial cerebrovascular disease (e.g. AVM)
- Known malignant intracranial neoplasm
- Ischemic stroke within 3mo
- Suspected aortic dissection
- Active bleeding or bleeding diathesis
- Recent surgery encroaching on the spinal canal or brain
- Recent closed-head or facial trauma w/ radiographic evidence of bony fx or brain injury
Relative contraindications
- Age >75 years
- Current use of anticoagulation
- PE in Pregnancy
- Noncompressible vascular punctures
- Traumatic or prolonged CPR (>10min)
- Recent internal bleeding (within 2 to 4 weeks)
- History of chronic, severe, and poorly controlled hypertension
- Severe uncontrolled HTN on presentation (sys BP >180 or dia BP >110)
- Dementia
- Remote (>3 months) ischemic stroke
- Major surgery within 3 weeks
IVC Filter
- Indications
- anticoagulation contraindicated in pt with PE
- failure to attain adequate anticoagulation during treatment
See Also
Thrombolytics for pulmonary embolism
- Clinical Page
- Research summary page: EBQ:Thrombolysis in Pulmonary Embolism Metanalysis
External Links
- MDCalc - Well's Criteria for Pulmonary Embolism
- MDCalc - PERC Rule for Pulmonary Embolism
- MDCalc - Geneva Score for Pulmonary Embolism
References
- ↑ D-Dimer Concentrations in Normal Pregnancy: New Diagnostic Thresholds Are Needed. Kline et all. Clinical Chemistry May 2005 vol. 51 no. 5 825-829 http://www.clinchem.org/content/51/5/825.long
- ↑ Righini M, Le GG, Aujesky D, et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet. 2008; 371(9621):1343-1352.
- ↑ Daniel KR, Jackson RE, Kline JA. Utility of the lower extremity venous ultrasound in the diagnosis and exclusion of pulmonary embolism in outpatients. Ann Emerg Med. 2000; 35(6):547-554.
- ↑ ACEP Clinical Policy. http://www.acep.org/Content.aspx?id=80787
- ↑ Elliott C. et al. Fibrinolysis of Pulmonary Emboli — Steer Closer to Scylla.
- ↑ Sharifi M et al. Moderate pulmonary embolism treated with thrombolysis (from the “MOPPETT trial). J Cardiol 2013; 111: 273-7
- ↑ Meyer G. Fibrinolysis for patients with intermediate-risk pulmonary embolism. NEJM 2014; 370(15): 1402-1411
- ↑ Chatterjee. S et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014; 311(23):2414-21. PubMed ID: 24938564.
- ↑ Thrombolysis_in_Pulmonary_Embolism_Metanalysis#Outcomes
- Circulation. 2011 Apr 26;123(16):1788-830
